(NASDAQ: ASRT) Assertio Holdings's forecast annual revenue growth rate of 8.47% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.56%.
Assertio Holdings's revenue in 2026 is $118,713,000.On average, 6 Wall Street analysts forecast ASRT's revenue for 2026 to be $754,921,708, with the lowest ASRT revenue forecast at $708,903,258, and the highest ASRT revenue forecast at $798,555,448. On average, 4 Wall Street analysts forecast ASRT's revenue for 2027 to be $882,278,089, with the lowest ASRT revenue forecast at $833,746,027, and the highest ASRT revenue forecast at $923,140,410.
In 2028, ASRT is forecast to generate $966,838,602 in revenue, with the lowest revenue forecast at $928,941,055 and the highest revenue forecast at $995,261,762.